Anthony Kirck
Comptroller/Controller/Auditor bij OPTINOSE, INC.
Vermogen: 130 309 $ op 30-04-2024
Actieve functies van Anthony Kirck
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
OPTINOSE, INC. | Comptroller/Controller/Auditor | 01-11-2021 | - |
Loopbaan van Anthony Kirck
Eerdere bekende functies van Anthony Kirck
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
VERRICA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 01-02-2020 | 01-11-2021 |
STRONGBRIDGE BIOPHARMA | Corporate Officer/Principal | 01-06-2017 | 01-02-2020 |
Opleiding van Anthony Kirck
Albright College | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Ierland | 2 |
Operationeel
Comptroller/Controller/Auditor | 2 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
OPTINOSE, INC. | Health Technology |
VERRICA PHARMACEUTICALS INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Strongbridge Biopharma Plc
Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
- Beurs
- Insiders
- Anthony Kirck
- Ervaring